As of 2025-07-01, the Relative Valuation of Albireo Pharma Inc (ALBO) is (81.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on Relative Valuation is -284.0%.
The range of the Relative Valuation is (62.59) - (111.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 17.7x | 12.6x |
| Forward P/E multiples | 9.9x - 20.1x | 13.1x |
| Fair Price | (62.59) - (111.77) | (81.24) |
| Upside | -241.8% - -353.2% | -284.0% |
| Date | P/E |